Emcure–Sanofi tie-up on anti-diabetic drugs

Pune‑based Emcure has secured exclusive rights to distribute and promote Sanofi India's oral anti-diabetics—such as Amaryl and Cetapin—across India. The deal aims to leverage Emcure’s strong network to enhance access and patient reach in managing type 2 diabetes